RL
69
-4
INTC
41
4
MMM
35
-5
EQT
51
-3
FTI
71
-7
REGN
38
-2
URBN
48
-6
TDC
67
-4
FITB
60
-5
GLW
45
-3
HBI
58
3
O
17
-13
ADBE
47
-9
PLD
45
-5
AXP
67
-2
BDX
56
10
AON
54
2
SHW
62
-6
CSCO
58
-2
EOG
56
-2
RL
69
-4
INTC
41
4
MMM
35
-5
EQT
51
-3
FTI
71
-7
REGN
38
-2
URBN
48
-6
TDC
67
-4
FITB
60
-5
GLW
45
-3
HBI
58
3
O
17
-13
ADBE
47
-9
PLD
45
-5
AXP
67
-2
BDX
56
10
AON
54
2
SHW
62
-6
CSCO
58
-2
EOG
56
-2
Financhill
Back

N-able Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
18

NABL
N-able

Last Price:
10.54
Seasonality Move:
-9.41%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
18
N-able (NABL) is a Sell

Is N-able a Buy, Sell or Hold?

  • The current N-able [NABL] share price is $10.54. The Score for NABL is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
  • NABL is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

NABL Stock Price Chart

What is N-able's stock price today?

  • The N-able share price today is $10.54
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NABL is experiencing selling pressure, which indicates risk of future bearish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

NABL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.47 Sell
Relative Strength Index (14 RSI): 20.56 Sell
Chaikin Money Flow: -453580 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (11.43 - 12.77) Sell
Bollinger Bands (100): (12.05 - 13.99) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

NABL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 11.3 Sell
20-day SMA: 11.98 Sell
50-day SMA: 12.39 Sell
200-day SMA: 13.08 Sell
8-day EMA: 11.2 Sell
20-day EMA: 11.76 Sell
50-day EMA: 12.29 Sell
200-day EMA: 12.9 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

N-able Earnings Growth & NABL Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.12 per share, and a decrease next year of $0.01 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.35 per share, and an increase next year of $0.56 per share.

N-able Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):